文献リスト

1) Pinto Slottow TL, Waksman R. Overview of the 2006 food and drug administration circulatory system devices panel meeting on drug-eluting stent thrombosis. Catheter Cardiovasc Interv. 2007; 69: 1064

2) Unger F. Drug eluting stents; a nightmare？. Interact Cardiovasc Thorac Surg. 2007; 6: 813

3) Hirotani T, Kameda T, Shirota S, et al. Coronary artery bypass grafting within 30 days of an acute myocardial infarction. Ann Thorac Cardiovasc Surg. 2001; 7: 28-34

4) Hirose H, Amano A, Takanashi S, et al. Coronary artery bypass grafting using the gastroepiploic artery in 1000 patients. Ann Thorac Surg. 2002; 73: 1371-9

5) Suma H, Tanabe H, Takahashi A, et al. Twenty years experience with the gastroepiploic artery graft for CABG. Circulation. 2007; 116 II Suppl: I188-91

6) Tatoulis J, Royse AG, Buxton BF, et al. The radial artery in coronary surgery: a 5-year experience-clinical and angiographic results. Ann Thorac Surg. 2002; 73: 143-8

7) Collins P, Webb CM, Chong CF, et al. Radial artery versus saphenous vein patency randomized trial; five-year angiographic follow-up. Circulation. 2008; 117: 2859-64

8) Nakajima H, Kobayashi J, Tagusari O, et al. Graft design strategies with optimum antegrade bypassflow in total arterial off-pump coronary artery bypass. Eur J Cardiothorac Surg. 2007; 31: 276-82

9) Fukui T, Takanashi S, Hosoda Y. Long segmental reconstruction of diffusely diseased left anterior descending coronary artery with left internal thoracic artery with or without endarterectomy. Ann Thorac Surg. 2005; 80: 2098-105

10) Shimizu T, Suesada H, Cho M, et al. Flow capacity of gastroepiploic artery versus vein grafts for intermediate coronary artery stenosis. Ann Thorac Surg. 2005; 80: 124-30

11) Gaudino M, Alessandrini F, Pragliola C, et al. Effect of target artery location and severity of stenosis on mid-term patency of aorta-anastomosed vs. internal thoracic artery-anastomosed radial artery grafts. Eur J Cardio Thorac Surg. 2004; 25: 424-8

12) Ueda U, Fujii Y, Udagawa H. Thoracic and cardiovascular surgery in Japan during 2006. Gen Thorac Cardiovasc Surg. 2008; 56: 365-88

13) Parolari A, Alammani F, Cannata A, et al. Off-pump versus on-pump coronary artery bypass; meta-analysis of currently available randomized trial. Ann Thorac Surg. 2003; 76: 37-40

14) Wijeysundera DN, Beattie WS, Djaiani G, et al. Off-pump coronary artery surgery for reducing mortality and morbidity; meta-analysis of randomized and observational studies. J Am Coll Cardiol. 2005; 46: 872-82

15) Sedrakyan A, Wu AW, Parashar A, et al. Off-pump surgery is associated with reduced occurrence of stroke and other morbidity as compared with traditional coronary artery bypass grafting; a meta-analysis of systematically reviewed trials. Stroke. 2006; 37: 2759-69

16) Puskas JD, Kilgo PD, Tattouf OM, et al. Off-pump coronary artery bypass provides reduced mortality and morbidity and equivalent 10-year survival. Ann Thorac Surg. 2008; 86: 1139-46

17) Kerendi F, Puskas JD, Craver JM, et al. Emergency coronary artery bypass grafting can be performed safely without cardiopulmonary bypass. Ann Thorac Surg. 2005; 79: 801-6

18) Takai H, Kobayashi J, Tagusari O, et al. Off-pump coronary artery bypass grafting for acute myocardial infarction. Circ J. 2006; 70: 1303-6

19) Edgerton JR, et al. On-pump beating heart surgery offers an alternative for unstable patients undergoing coronary artery bypass grafting. Heart Surg Forum. 2004; 7: 8-15

20) Cheng DC, Bainbridge D, Martin JE, et al. Does off-pump coronary artery bypass reduce mortality, morbidity, and resource when compared with conventional coronary artery bypass？ A meta-analysis of randomized trials. Anesthesiology. 2005; 102: 188-203

21) Taggart DP, Lees B, Gray A, et al. Protocol for the Arterial Revascularization Trial (ART). A randomised trial to cmpare survival following bilateral versus single internal mammary grafting revascularization. Trials. 2006; 7: 7

22) Booth J, Clayton T, Pepper J, et al. Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease; six-year follow-up from the stent or surgery trial (SoS). Circulation. 2008; 118: 381-8

23) Bavry AA, Kumbhani DJ, Rassi AN, et al. Benefit of early invasive therapy in acute coronary syndromes; a meta-analysis of contemporary randomized clinical trials. J Am Coll Cardiol. 2006; 48: 1319-25

24) Eagle KA, Guyton RA, Davidoff R, et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery; a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation. 2004; 110: e340-437

25) Mehta SR, Cannon CP, Fox KAA, et al. Routine vs selective invasive strategies in patients with acute coronary syndromes; a collaborative meta-analysis of randomized trials. JAMA. 2005; 293: 2908-17

26) 山口 徹, 一色高明, 井野隆史, 他. 急性冠症候群の診療に関するガイドライン(2007年改訂版). Circ J. 2007; 71 Suppl. http://www.j-ciro.or.jp/guidline/pdf/JCS2007_yamaguchi_h.pdf

27) Yusuf S, Zucker D, Peduzzi P, et al. Effect of coronary artery bypass graft surgery on survival; overview of 10-year results from randomised trials by the coronary artery bypass graft surgery trialists collaboration. Lancet. 1994; 344: 563-70

28) Katritsis DG, Ioannidis JPA. Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease; a meta-anaysis. Circulation. 2005; 111: 2906-12

29) Boden WE, O'Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007; 356: 1503-16 (COURAGE Trial)

30) Weintraub WS, Spertus JA, Kolm P, et al. Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med. 2008; 359: 677-87 (COURAGE Trial)

31) Hochman JS, Lamas GA, Buller CE, et al. Coronary intervention for persistent occulusion after myocardial infarction. N Engl J Med. 2006; 355: 2395-407 (Open Artery Trial: OAT)

32) Bravata DM, Gienger AL, McDonald KM, et al. Systemic Review; the comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery. Ann Intern Med. 2007; 147: 703-16

33) Serruys PW, Ong AT, van Herwerden LA, et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol. 2005; 46: 575-81

34) Detre KM, Lombardero MS, Brooks MM, et al. The effect of preveous coronary-artery bypass surgery on the prognosis of patients with diabetes who have acute myocardial infarction. N Engl J Med. 2000; 342: 989-97

35) Ohno T, Ando J, Ono M, et al. The beneficial effect of coronary-artery-bypass surgery on survival in patients with diabetic retinopathy. Eur J Cardiovasc Surg. 2006; 30: 881-6

36) Kastrati A, Mehilli J, Pache J, et al. Analysis of 14 trials ccomparing sirolimus-eluting stents with bare-metal stents. N Engl J Med. 2007; 356: 1030-9

37) Stone GW, Moses JW, Ellis SG, et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med. 2007; 356: 998-1008

38) Lagerqvist B, James SK, Stenestrand U, et al. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med. 2007; 356: 1009-19

39) McFadden EP, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet. 2004; 364: 1519-21

40) Machecourt J, Danchin N, Lablanche JM, et al. Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients. J Am Coll Cardiol. 2007; 50: 501-8

41) Hannan EL, Racs MJ, Walford G, et al. Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med. 2005; 352: 2174-83

42) Brener SJ, Lytle BW, Casserly IP, et al. Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high risk features. Circulation. 2004; 109: 2290-5

43) Hannan EL, Wu C, Walford G, et al. Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med. 2008; 358: 331-41

44) Taggart DP. Coronary artery bypass grafting is still the best treatment for multivessel and left main disease, but patients need to know. Ann Thorac Surg. 2006; 82: 1966

45) Kazui T, Osada H, Fujita H. An attempt to analyze the relationship between hospital surgical volume and clinical outcome. Gen Thorac Cardiovasc Surg. 2007; 55: 483-92

46) Miyata H, Motomura N, Ueda Y, et al. Effect of procedural volume on outcome of coronary artery bypass graft surgery in Japan; implication toward public reporting and minimal volume standards. J Thorac Cardiovasc Surg. 2008; 135: 1306-12. Comment in J Thorac Cardiovasc Surg. 2008; 135: 1202-9

47) Cheng S, Jarcho J. Management of stable coronary disease; polling results. N Engl J Med. 2007; 357: e28

NPO医学中央雑誌刊行会 https://www.jamas.or.jp/ info@jamas.or.jp